Toronto Ultra, a CDL franchise owned by OverActive Media, has announced it has extended its existing partnership with ...

A CRN analysis found that Nvidia finished the first quarter with more than double the revenue of what Intel and AMD earned ...

The Detroit Lions ' running back duo of Jahmyr Gibbs and David Montgomery played well enough to receive new nicknames last ...

A massive insider purchase just hit Advanced Micro Devices (AMD), and it’s raising eyebrows across Wall Street. Philip Guido, ...

LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

AMD's margins are quickly ticking up, and Wall Street is anticipating this. As a result, they expect strong earnings growth ...

The pivotal phase 3 clinical trial is the first of 2 that will evaluate the use of DURAVYU for the treatment of wet age-related macular degeneration.

LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...

We recently published a list of 10 AI Stocks Making Waves This Week. In this article, we are going to take a look at where ...

A top executive at Advanced Micro Devices Inc. (NASDAQ: AMD) made a sizable open market purchase in the stock this week, ...